Heparin and protamine requirements of patients in chronic renal failure.
Akpek
E A
EA
Department of Anesthesiology, Başkent University Faculty of Medicine, Ankara, Turkey.
Dönmez
A
A
Erol
E
E
Sekerci
S
S
Arslan
G
G
D000328:Adult; D000758:Anesthesia / Q000379:methods; D000925:Anticoagulants / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures; D001026:Coronary Artery Bypass; D005260:Female; D019918:Heart Valve Prosthesis Implantation; D006493:Heparin / Q000627:therapeutic use*; D006494:Heparin Antagonists / Q000627:therapeutic use*; D006801:Humans; D007036:Hypothermia, Induced; D007430:Intraoperative Care; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011479:Protamines / Q000627:therapeutic use*; D006435:Renal Dialysis; D012189:Retrospective Studies
D000925:Anticoagulants; D006494:Heparin Antagonists; D011479:Protamines; D006493:Heparin